Terug
Dagbereik
€ 6,58
€ 8,77
52-Weeksbereik
€ 5,30
€ 25,00
Volume
138.671
50D / 200D Gem.
€ 9,76
/
€ 12,68
Vorige Slotkoers
€ 6,49
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -386,2 | 0,4 |
| P/B | 82,7 | 2,9 |
| ROE % | -42,7 | 3,9 |
| Net Margin % | -276,6 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Belangrijkste Punten
Earnings declined -10509,73% over the past year
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -4,75M
PEG of 0,00 suggests growth is underpriced
Capital intensive — 570,38% of revenue goes to capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)45,76%
Earnings (1Y)-10509,73%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-42,69%
ROIC-16,58%
Net Margin-276,58%
Op. Margin-286,45%
Veiligheid
Debt / Equity
0,00
Current Ratio13,18
Interest Coverage-1893,69
Waardering
P/E Ratio
-386,19
P/B Ratio82,72
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 45,76% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | -10509,73% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 510.360,0 | Net Income (TTM) | -1,41M |
| ROE | -42,69% | ROA | -20,56% |
| Gross Margin | 30,44% | Operating Margin | -286,45% |
| Net Margin | -276,58% | Free Cash Flow (TTM) | -4,75M |
| ROIC | -16,58% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 13,18 |
| Interest Coverage | -1893,69 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -386,19 | P/B Ratio | 82,72 |
| P/S Ratio | 1068,13 | PEG Ratio | 0,00 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 545,13M | Enterprise Value | 542,02M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 510.360,0 | 350.131,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -1,41M | 13.560,0 | 3,79M | 8,70M | -2,54M |
| EPS (Diluted) | -0,56 | 0,00 | 0,41 | 0,59 | -0,17 |
| Gross Profit | 155.356,0 | 153.445,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -1,46M | -9.847,0 | -2,32M | -1,72M | -344.223,0 |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 6,86M | 321.212,0 | 17,93M | 118,06M | 117,59M |
| Total Liabilities | 273.980,0 | 298.218,0 | 6,74M | 9,11M | 17,81M |
| Shareholders' Equity | 6,59M | 22.994,0 | 11,20M | 108,96M | 99,78M |
| Total Debt | 22.555,0 | 47.576,0 | 0,0 | 0,0 | 0,0 |
| Cash & Equivalents | 3,13M | 87.098,0 | 14.129,0 | 5.403,0 | 693.818,0 |
| Current Assets | 3,47M | 271.724,0 | 202.705,0 | 129.560,0 | 830.767,0 |
| Current Liabilities | 263.060,0 | 298.218,0 | 5,55M | 2,00M | 302.219,0 |